Cochrane Abstracts
Artemisinin derivatives for treating severe malaria Unchanged
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Artemisinin Derivatives for Treating Severe Malaria Unchanged." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439412/all/Artemisinin_derivatives_for_treating_severe_malaria_Unchanged. Accessed 02 June 2023.
Artemisinin derivatives for treating severe malaria Unchanged. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439412/all/Artemisinin_derivatives_for_treating_severe_malaria_Unchanged. Accessed June 2, 2023.
Artemisinin derivatives for treating severe malaria Unchanged. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/439412/all/Artemisinin_derivatives_for_treating_severe_malaria_Unchanged
Artemisinin Derivatives for Treating Severe Malaria Unchanged [Internet]. In: Cochrane Abstracts. [cited 2023 June 02]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439412/all/Artemisinin_derivatives_for_treating_severe_malaria_Unchanged.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Artemisinin derivatives for treating severe malaria Unchanged
ID - 439412
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439412/all/Artemisinin_derivatives_for_treating_severe_malaria_Unchanged
DB - Evidence Central
DP - Unbound Medicine
ER -
